Open Payments Expansion Act

# Open Payments Expansion Act Summary The Open Payments Expansion Act would expand the existing "Open Payments" program, which requires pharmaceutical and medical device companies to publicly report payments and gifts they give to doctors and teaching hospitals. Currently, the program captures certain types of payments, but this bill would broaden what companies must disclose, likely including additional categories of financial relationships between industry and healthcare providers. The bill would primarily affect pharmaceutical and medical device manufacturers, physicians, and teaching hospitals. Patients and the general public would potentially benefit from increased transparency about financial relationships that could influence medical treatment decisions.

The expanded disclosures would make it easier for patients and doctors to identify potential conflicts of interest when making healthcare decisions. **Current Status:** The bill is currently in committee, meaning it has been introduced but has not yet advanced to a full vote in the Senate. No further action has been taken as of the latest information available.